#BEGIN_DRUGCARD DB03988

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C6H16N3O

# Chemical_IUPAC_Name:
(5S)-5-amino-5-carbamoylpentan-1-aminium

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2,6-Diamino-Hexanoic Acid Amide

# HET_ID:
LYN

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H15N3O/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H2,9,10)/p+1/t5-/m0/s1

# InChI_Key:
InChIKey=HKXLAGBDJVHRQG-YFKPBYRVSA-O

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3988

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
146.2107

# Molecular_Weight_Mono:
146.129337149

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1GEA

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.6

# Predicted_LogS:
-1.2

# Predicted_Water_Solubility:
1.04e+01 g/l

# Primary_Accession_No:
DB03988

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
17754068

# PubChem_Substance_ID:
46506171

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02078

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CCCC[NH3+])C(N)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:49 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
ADCYAP1

# Drug_Target_1_GenBank_ID_Gene:
S83513

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ADCYAP1

# Drug_Target_1_Gene_Sequence:
>531 bp
ATGACCATGTGTAGCGGAGCGAGGCTGGCCCTGCTGGTCTATGGGATAATCATGCACAGC
AGCGTCTACAGCTCACCTGCCGCCGCCGGACTCCGGTTCCCCGGGATCAGGCCAGAGGAA
GAGGCGTACGGCGAGGACGGAAACCCGCTGCCAGACTTCGGTGGCTCGGAGCCGCCGGGC
GCAGGGAGCCCCGCCTCCGCGCCGCGCGCCGCCGCCGCCTGGTACCGCCCGGCCGGGAGA
AGAGATGTCGCCCACGGGATCCTTAACGAGGCCTACCGCAAAGTGCTGGACCAGCTGTCC
GCCGGGAAGCACCTGCAGTCGCTCGTGGCCCGGGGCGTGGGTGGGAGCCTCGGCGGCGGC
GCGGGGGACGACGCGGAGCCGCTCTCCAAGCGCCACTCGGACGGGATCTTCACGGACAGC
TACAGCCGCTACCGGAAACAAATGGCTGTCAAGAAGTACTTGGCGGCCGTCCTAGGGAAG
AGGTATAAACAAAGGGTTAAAAACAAAGGACGCCGAATAGCTTATTTGTAG

# Drug_Target_1_General_Function:
Involved in hormone activity

# Drug_Target_1_General_References:
11968092	Gu HF: Genetic variation screening and association studies of the adenylate cyclase activating polypeptide 1 (ADCYAP1) gene in patients with type 2 diabetes. Hum Mutat. 2002 May;19(5):572-3.
1483839	Inooka H, Endo S, Kitada C, Mizuta E, Fujino M: Pituitary adenylate cyclase activating polypeptide (PACAP) with 27 residues. Conformation determined by 1H NMR and CD spectroscopies and distance geometry in 25% methanol solution. Int J Pept Protein Res. 1992 Nov;40(5):456-64.
1730060	Hosoya M, Kimura C, Ogi K, Ohkubo S, Miyamoto Y, Kugoh H, Shimizu M, Onda H, Oshimura M, Arimura A, et al.: Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. Biochim Biophys Acta. 1992 Jan 6;1129(2):199-206.
1739432	Ohkubo S, Kimura C, Ogi K, Okazaki K, Hosoya M, Onda H, Miyata A, Arimura A, Fujino M: Primary structure and characterization of the precursor to human pituitary adenylate cyclase activating polypeptide. DNA Cell Biol. 1992 Jan-Feb;11(1):21-30.
2302217	Kimura C, Ohkubo S, Ogi K, Hosoya M, Itoh Y, Onda H, Miyata A, Jiang L, Dahl RR, Stibbs HH, et al.: A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs. Biochem Biophys Res Commun. 1990 Jan 15;166(1):81-9.
8504103	Wray V, Kakoschke C, Nokihara K, Naruse S: Solution structure of pituitary adenylate cyclase activating polypeptide by nuclear magnetic resonance spectroscopy. Biochemistry. 1993 Jun 8;32(22):5832-41.

# Drug_Target_1_HGNC_ID:
HGNC:241

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5480

# Drug_Target_1_Locus:
18p11

# Drug_Target_1_Molecular_Weight:
18836

# Drug_Target_1_Name:
Pituitary adenylate cyclase-activating polypeptide

# Drug_Target_1_Number_of_Residues:
176

# Drug_Target_1_PDB_ID:
1GEA

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00123	Hormone_2

# Drug_Target_1_Protein_Sequence:
>Pituitary adenylate cyclase-activating polypeptide
MTMCSGARLALLVYGIIMHSSVYSSPAAAGLRFPGIRPEEEAYGEDGNPLPDFDGSEPPG
AGSPASAPRAAAAWYRPAGRRDVAHGILNEAYRKVLDQLSAGKHLQSLVARGVGGSLGGG
AGDDAEPLSKRHSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNKGRRIAYL

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-24

# Drug_Target_1_Specific_Function:
Stimulates adenylate cyclase in pituitary cells

# Drug_Target_1_SwissProt_ID:
P18509

# Drug_Target_1_SwissProt_Name:
PACA_HUMAN

# Drug_Target_1_Synonyms:
PACAP
Pituitary adenylate cyclase-activating polypeptide precursor

# Drug_Target_1_Theoretical_pI:
10.24

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03988
